Bacteria constantly release tiny biological bubbles known as bacterial membrane vesicles (BMVs), which carry proteins and genetic material—including antibiotic‑resistance genes. These vesicles act like molecular messages, offering early clues about infection, resistance, and microbial activity in both clinical and environmental settings. However, in real‑world samples such as wastewater, soil, or blood, BMVs are buried in a dense mix of debris, free DNA, and viruses. Traditional isolation methods—such as ultracentrifugation, density‑gradient separation, filtration, and size‑exclusion chromatography—often pull in particles of similar size or density, resulting in contaminated preparations. These conventional strategies frequently co‑isolate extracellular plasmids and bacteriophages, making it difficult to accurately study vesicle‑associated antibiotic‑resistance genes.
GW researchers developed PureVesicles to directly address this challenge using a selective immunocapture approach that takes advantage of natural differences between Gram‑positive and Gram‑negative bacteria. Gram‑positive vesicles display lipoteichoic acid (LTA) on their surface, while Gram‑negative vesicles display lipopolysaccharide (LPS)—two well‑established biomarkers that allow precise targeting. By using antibodies that bind specifically to LTA or LPS, the system “locks onto” the correct vesicles and pulls them out magnetically, leaving behind free DNA, phages, and other contaminants. This method achieved 98% recovery for Gram‑positive vesicles and 87% for Gram‑negative vesicles, with minimal cross‑reactivity, enabling clean, origin‑specific vesicle preparations suitable for downstream analysis
Figure 1: PureVesicles Isolation Workflow. Sequential workflow for isolating bacterial membrane vesicles from wastewater using filtration, ultrafiltration, antibody binding, magnetic capture, and low‑pH elution to obtain purified vesicles
Advantages
Applications